PHAT ▼ -0.1% - Phathom Pharmaceuticals, Inc.
$PHAT - Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
12-OCT-2026 08:00 AM ET
Share this post
More filings for $PHAT
PHAT ▲ +6.4% - Phathom Pharmaceuticals, Inc.Oct 29, 2026PHAT ▼ -2.1% - Phathom Pharmaceuticals, Inc.Oct 23, 2026PHAT ▲ +1.6% - Phathom Pharmaceuticals, Inc.Oct 19, 2026PHAT ▼ -0.3% - Phathom Pharmaceuticals, Inc.Oct 8, 2026PHAT ▼ -0.6% - Phathom Pharmaceuticals, Inc.Sep 1, 2026$PHAT SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $PHAT filing history →💬 Comments
Loading comments…
Leave a comment